Cerus Campus

Welcome to the Cerus Campus

Your video library for expert views and insights on blood safety

Introducing the Cerus Campus, a central source for videos with information and insights on the field of blood safety, featuring medical professionals from around the globe. Here you’ll find presentations and videos from leading experts on a range of topics, including blood safety, cost-effective solutions to prevent TTI, and the impact of the COVID-19 pandemic on blood supply.

With the goal to share new findings, discoveries and opinions directly from medical professionals, the Cerus Campus is a valuable source of information.
To stay up-to-date on developments in the world of blood safety, sign up to be notified by email whenever a new presentation or video is posted. All content will be posted in English, with additional languages when available.

Dr. Luisa Maria Barea Garcia, MD

Dr. Barea is a MD, specialist in hematology and hemotherapy, her working life has been developed in the field of transfusion medicine in several transfusion centers and services. Dr. Barea have run the Transfusion Center of the Community of Madrid for 7 years.

Dr. Richard J. Benjamin, MBChB, PhD, FRCPath

Dr. Benjamin was appointed as Chief Medical Officer in July 2015. Previously, he served as CMO for the American Red Cross. Prior to Red Cross, he served as medical director at the Adult Transfusion Service at the Joint Program in Transfusion Medicine at Harvard University.

Dr. Benjamin is a Board Member and Regional Director for North America for the International Society of Blood Transfusion, as well as an active member of the American Association of Blood Banks. He has also served on the DHHS Secretary’s Advisory Committee on Blood Safety and Availability in the U.S. Dr. Benjamin is an Adjunct Associate Professor of Pathology at Georgetown University and author of 100 peer-reviewed publications.

Prof. Dr. Paul Coppo, MD

Paul Coppo is professor of Haematology at Sorbonne University in Paris. He heads the French reference center for thrombotic microangiopathies (CNR-MAT) and the department of lymphoid malignancies in Saint-Antoine hospital (Paris, France), involved in the management of rare lymphoid malignancies and other immuno-hematological diseases. He is member of the team Immunopathology and Immuno-intervention (INSERM UMRS 1138, Centre de Recherche des Cordeliers, Sorbonne University).

The works of his team include clinical trials and translational research works which have been published in Blood, Leukemia, Lancet Haematology, Haematologica and the Journal of Thrombosis and Haemostasis.

Dr. Laurence M. Corash, MD

Dr. Corash, a co-founder of Cerus, was appointed as our Chief Scientific Officer in 2009. He has held various medical positions within the company, including Chief Medical Officer from 1994-2015. Dr. Corash was a consultant to us from 1991 to 1994. He has been a Professor of Laboratory Medicine at the University of California, San Francisco since July 1985 and was Chief of the Hematology Laboratory for the Medical Center at the University of California, San Francisco from 1982 to 1997. From February 1990 to July 1994, Dr. Corash was a consultant to the FDA Advisory Panel for Hematology Devices. He currently serves on the U.S. Health and Human Services’ Advisory Committee on Blood Safety and Availability.

Prof. Dr. med Ulf Dittmer

Ulf Dittmer studied biology in Bremen, Germany. He received his Ph.D. in Virology from the University of Göttingen, Germany. He did his postdoctoral training at the German Primate Center in Göttingen and at the Rocky Mountain Laboratories, NIAID, NIH in Hamilton, Montana, USA. In 2011 he became director of the Institute for Virology at the University Hospital Essen, University of Duisburg-Essen, Germany and in 2013 of the West German Center for Infectious Diseases. His research is focused on viral immunity.

His research is focused on immune responses against chronic virus infections, with a special emphasis on retroviral immunity. His goal is to develop novel immunotherapies to overcome viral persistence.

Dr. sc. nat. David Goslings, MBA

Dr. David Goslings studied biology at the ETH Zurich in Switzerland and graduated with a PhD thesis in molecular biology. Afterwards, he worked at the QC department of an international pharmaceutical company and later on moved to Blood Transfusion Service Zurich where he is now member of the executive board and responsible for the business unit Laboratories and Production.

Prof. Salwa Ibrahim Hindawi

Haematology & Transfusion Medicine Consultant and King Abdulaziz University, Jeddah Saudi Arabia

Vice President & Chief Scientific Officer of Saudi Society of Transfusion Medicine and Member of WHO advisory panel on Blood Transfusion Safety

Priv-Doz. Dr. med. Ulrich Kalus

Specialist in transfusion medicine and senior physician. Dr. Kalus works at the Charité-Berlin for many years, competent person and head of the haemapheresis/blood donation department, qualified as a professor in the field of serological infection testing of tissue donors, parallel clinical.

Dr. Ryan A. Metcalf, MD, CQA

Dr. Metcalf is the Medical Director of the Transfusion Medicine Service at University of Utah Health and ARUP Laboratories and is an Assistant Professor of Pathology. He also serves as Inpatient Chief Value Officer for the Department of Pathology at the University of Utah. He completed a residency in Anatomic and Clinical Pathology and a fellowship in Transfusion Medicine at Stanford University and is board certified in these disciplines. Dr. Metcalf practices transfusion medicine and his specific interests include data-driven approaches to improve understanding of transfusion reactions, patient blood management, and innovation. He also has expertise in quality management and is a Certified Quality Auditor. He is a member of the AABB Clinical Transfusion Medicine Committee, the AABB Patient Blood Management Standards Committee, and the College of American Pathologists (CAP) Transfusion, Apheresis, and Cellular Therapy Committee.

Dr. Shibani Pati, MD, PhD

Dr. Pati is a vascular biologist with an interest in the role of endothelial dysfunction and vascular compromise in the pathogenesis of human disease. The specific areas of investigation involve the use of stem cells and novel resuscitative modalities that can mitigate endothelial dysfunction in traumatic injury.

Mr. Jean-Marc Payrat

Jean-Marc Payrat is a bio-engineer from the University of Compiègne (UTC) in France (1982). He worked for 4 years as Blood Component Laboratory Manager at the National Blood Transfusion Center (CNTS) in Les Ulis (Paris) while completing certificates in Transfusion Medicine and Immunology at the University Pierre et Marie Curie - Paris VI. He joined Baxter R&D Europe (Fenwal Division), Nivelles, then Fenwal Europe, Mont-Saint-Guibert, both in Belgium, and held over 26 years, Product Development, Clinical Education and Scientific Support Management positions in the field of medical devices for collection, processing and storage of blood components. Since 2014, Jean-Marc Payrat holds a position of Director Development & Research within the Scientific Affairs team of Cerus Europe, Amersfoort, The Netherlands, developing and commercializing pathogen inactivation systems for blood components (INTERCEPT^TM Blood System).

Dr. Sandra Ramirez-Arcos, PhD

Dr. Sandra Ramirez-Arcos trained as a microbiologist in her native Colombia and then conducted PhD studies in Biological Sciences in Spain. From 1998 to 2002, Dr. Ramirez did her post-doctoral training and worked as a research associate at the University of Ottawa. Since 2003, she has worked at Canadian Blood Services where she currently holds a Senior Scientist position. Dr. Ramirez is also an Adjunct Professor at the University of Ottawa.

Dr. Ramirez has built a strong team with expertise on bloodborne bacteria. Her laboratory oversees the development, validation and implementation of protocols and processes aimed at enhancing blood component safety.

Dr. Susan Stramer, PhD

Dr. Stramer is the Vice President of Scientific Affairs at the American Red Cross. She was previously Chair of the AABB Transfusion-Transmitted Diseases Committee, and President of AABB. Dr. Stramer obtained her PhD in Bacteriology at the University of Wisconsin in 1984 and was a postdoctoral research fellow at CDC’s hepatitis branch. She also worked in the areas of product development and support for ~10 years at Abbott Laboratories before joining the Red Cross. She is the recipient of numerous awards including the CDC’s Charles C. Shepard Science Award and the NIH’s Rick Davey Lectureship Award.

Dr. Mohammad R. Abedi, MD, PhD

Dr. Mohammad R. Abedi is working as an consultant Clinical Immunology and Transfusion Medicine at the Örebro University Hospital in Stockholm, Sweden. He received his PhD Immunology at the Karolinska Institute and his MD at the University of Tehran.

Welcome to the Cerus Campus

Your video library for expert views and insights on blood safety

Expert views / Library

Stanford Blood Center - the first blood center of its size to implement pathogen reduction for 100% of platelet components

Production and in vitro quality of pooled whole blood derived PI plasma

Evolution of the level of blood safety and impact on patient safety: a historic perspective

Bacterial contamination rate of platelet components by primary culture and residual risk associated with false negatives: results from two recent
meta-analyses

Ordering platelet concentrates: does pathogen inactivation matter to the clinician?

Meet the Blood Transfusion Professionals

Ask a Cerus Expert

Welcome to the Cerus Campus

Your video library for expert views and insights on blood safety

Expert views / Library

Stanford Blood Center - the first blood center of its size to implement pathogen reduction for 100% of platelet components

Production and in vitro quality of pooled whole blood derived PI plasma

Evolution of the level of blood safety and impact on patient safety: a historic perspective

Bacterial contamination rate of platelet components by primary culture and residual risk associated with false negatives: results from two recent meta-analyses

Ordering platelet concentrates: does pathogen inactivation matter to the clinician?

Meet the Blood Transfusion Professionals

Newsletter

Ask a Cerus Expert

Bacterial contamination rate of platelet components by primary culture and residual risk associated with false negatives: results from two recent
meta-analyses